Conversely, in gliomas and pancreatic ductal adenocarcinomas, tumors with high levels of HHLA2 expression had a better prognosis, suggesting that it may act as a co-stimulator through the TMIGD2 pathway (24, 25). The gene discussed is HHLA2; the disease is pancreatic ductal adenocarcinoma.